PT - JOURNAL ARTICLE AU - F. Lowry TI - Compound could help diabetic patients walk tightrope between heperglycemia, hypoglycemia DP - 1996 Mar 01 TA - Canadian Medical Association Journal PG - 705--707 VI - 154 IP - 5 4099 - http://www.cmaj.ca/content/154/5/705.short 4100 - http://www.cmaj.ca/content/154/5/705.full SO - CMAJ1996 Mar 01; 154 AB - A pharmaceutical company is proceeding with clinical testing of a new compound that could make it easier for diabetic patients to maintain good control of blood-sugar levels. The compound, a peptide called amylin, appears to lessen wild fluctuations in blood-glucose levels by slowing the rate of gastric emptying and moderating the amount of postprandial glucose. Fran Lowry interviewed the researcher who discovered the peptide.